| Literature DB >> 26479384 |
Zhangrui Cheng1, Chike F Oguejiofor2, Theerawat Swangchan-Uthai3, Susan Carr4, D Claire Wathes5.
Abstract
Both high and low circulating urea concentrations, a product of protein metabolism, are associated with decreased fertility in dairy cows through poorly defined mechanisms. The rate of involution and the endometrial ability to mount an adequate innate immune response after calving are both critical for subsequent fertility. Study 1 used microarray analysis to identify genes whose endometrial expression 2 weeks postpartum correlated significantly with the mean plasma urea per cow, ranging from 3.2 to 6.6 mmol/L. The biological functions of 781 mapped genes were analysed using Ingenuity Pathway Analysis. These were predominantly associated with tissue turnover (e.g., BRINP1, FOXG1), immune function (e.g., IL17RB, CRISPLD2), inflammation (e.g., C3, SERPINF1, SERPINF2) and lipid metabolism (e.g., SCAP, ACBD5, SLC10A). Study 2 investigated the relationship between urea concentration and expression of 6 candidate genes (S100A8, HSP5A, IGF1R, IL17RB, BRINP1, CRISPLD2) in bovine endometrial cell culture. These were treated with 0, 2.5, 5.0 or 7.5 mmol/L urea, equivalent to low, medium and high circulating values with or without challenge by bacterial lipopolysaccharide (LPS). LPS increased S100A8 expression as expected but urea treatment had no effect on expression of any tested gene. Examination of the genes/pathways involved suggests that plasma urea levels may reflect variations in lipid metabolism. Our results suggest that it is the effects of lipid metabolism rather than the urea concentration which probably alter the rate of involution and innate immune response, in turn influencing subsequent fertility.Entities:
Keywords: cholesterol; endometrium; innate immunity; involution; protein metabolism
Year: 2015 PMID: 26479384 PMCID: PMC4598704 DOI: 10.3390/ani5030382
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Details of the genes assessed by quantitative RT-PCR.
| Gene Symbol | Primer Sequence 5′→3′ | Product Size (bp) * | GenBank Accession No. |
|---|---|---|---|
| F: CGGCGACGACCCATTCGAAC | 99 | NR_036642.1 | |
| R: AATCGAACCCTGATTCCCCGTC | |||
| F: TGCCATTAACTCCCTGATTGAC | 179 | NM_001113725.1 | |
| R: TAATTCCACCATCCTGATTGAT | |||
| F: GGTATTGAAACTGTGGGAGGTG | 119 | NM_001075148.1 | |
| R: AAGGTGATTGTCTTTCGTCAGG | |||
| F: GATCCCGTGTTCTTCTACGTTC | 101 | NM_001244612.1 | |
| R: AAGCCTCCCACTATCAACAGAA | |||
| F: AAAGCCACTTCCAGTCCTACAG | 179 | NM_001083467.1 | |
| R: ACCGTCCTCATTCATATTTGC | |||
| F: ACTGGAGCAATCAAGGTCACA | 173 | NM_001015669.1 | |
| R: GCCGACTGGACGAACTTCT | |||
| F: ACTGAAACGGACGACATGAAC | 175 | NM_001100299.1 | |
| R: TGGACCCTTTACACTTGTCCTT |
F (forward); R (reverse); * base pairs.
Matrix of Pearson correlations between energy balance and circulating metabolite and hormone concentrations at 14 ± 0.4 days postpartum with the circulating white blood cell count and the uterine inflammatory cell population (n = 11 cows) #.
# Results have been combined for the 5 cows on the MNEB and 6 on the SNEB treatment groups. The blood values used were those taken pre-slaughter. EB, energy balance; INS, insulin; GLUC, glucose; WBC, circulating white blood cells; SEGepi and SEGst, segmented cells in uterine epithelium and stroma; MCepi, and MCst mononuclear cells (macrophages and lymphocytes) in uterine epithelium and stroma; LYFOCst, No. lymphocytic foci in stroma. The Pearson correlation is shown above. The actual p value is given below. Using a Benjamini Hochberg false discovery rate correction for 13 × 13 comparisons, adjusted 5% significance is at p = 0.025 and adjusted 1% significance is at p = 0.005, shown in bold. NS, not significant.
Ingenuity Pathway Network Analysis of the genes significantly correlated with mean plasma urea concentrations showing the top 4: (1) disease processes and biological functions; (2) canonical pathways and (3) network functions.
| No. Genes | Disease Processes and Biological Functions | |
|---|---|---|
| <0.001 | 32 | Endocrine system disorders |
| <0.001 | 28 | Haematological disease |
| <0.001 | 49 | Cellular function and maintenance |
| <0.001 | Cellular growth and proliferation | |
| 0.01 | 10/136 | Corticotrophin releasing hormone signalling |
| 0.016 | 5/38 | Coagulation system |
| 0.022 | 5/68 | Retinoic acid mediated apoptosis signalling |
| 0.026 | 10/131 | LXR/RXR Activation |
| 43 | 29 | Endocrine system development, lipid metabolism, molecular transport |
| 40 | 27 | Cell-to-cell signaling and interaction, tissue development |
| 38 | 26 | Lipid metabolism, molecular transport, small molecule biochemistry |
| 38 | 26 | Cell-to-cell signaling and interaction, haematological system development and function, haematopoiesis |
a The number of genes in the list of DEGs that participate in the canonical pathway divided by the total number of genes that are known to be associated with the pathway in the Ingenuity knowledge base; b A higher network score corresponds to a lower probability of finding the observed number of the DEGs in a given network by chance.
Summary information on the top 10 genes expressed in bovine endometrium which were most highly correlated with the plasma urea concentration plus an additional 3 genes selected for the follow-up study.
| Gene Symbol | Unigene ID | Gene Title | Entrez Gene | r | P |
|---|---|---|---|---|---|
| Bt.35142 | Bone morphogenetic protein/retinoic acid inducible neural-specific 1 | 538990 | −0.896 | 0.0002 | |
| Bt.66213 | Forkhead box G1 | 516947 | −0.894 | 0.0002 | |
| Bt.24532 | Interleukin 17 receptor B | 533605 | −0.892 | 0.0002 | |
| Bt. 87957 | Acyl-coenzyme A binding domain containing 5 | 353160 | +0.883 | 0.0003 | |
| Bt.51814 | Solute carrier family 10 (sodium/bile acid co-transporter family), member 1 | 532890 | −0.875 | 0.0004 | |
| Bt.22353 | Serine/arginine repetitive matrix 2 | 539515 | −0.869 | 0.0005 | |
| --- | X (inactive)-specific transcript | 338325 | +0.864 | 0.0006 | |
| --- | Ribokinase | 513276 | −0.862 | 0.0006 | |
| Bt.55503 | Cysteine-rich secretory protein LCCL domain containing 2 | 505329 | −0.859 | 0.0007 | |
| Bt.18085 | SREBF chaperone | 507878 | +0.858 | 0.0007 | |
| Bt. 9360 | S100 calcium binding protein A8 | 616818 | +0.624 | 0.04 | |
| Bt.65104 | Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) | 415113 | +0.580 | 0.06 | |
| Bt.12759 | Insulin-like growth factor 1 receptor | 281848 | +0.609 | 0.05 | |
# Previously named DBC1, Deleted in bladder cancer 1; + Also known as GRP78.
Figure 1Scatter plots showing the relationships between the mean plasma urea concentration from each of 13 cows and the gene expression level measured in their endometrium at 2 weeks postpartum using microarray analysis, normalized by overall expression within the chip.
Molecules in each of the top 4 networks and canonical pathways in endometrium of 11 postpartum cows identified by IPA analysis as being correlated with their mean plasma urea value.
| Network | Molecules in Network |
|---|---|
| Endocrine system development, lipid metabolism, molecular transport | Alpha tubulin, |
| Cell-to-cell signaling and interaction, tissue development | Aconitase, |
| Lipid metabolism, molecular transport, small molecule biochemistry | |
| Cell-to-cell signaling and interaction, haematological system development and function, haematopoiesis | |
| Corticotropin Releasing Hormone Signalling | |
| Coagulation System | |
| Retinoic acid Mediated Apoptosis Signaling | |
| LXR/RXR Activation |
Effects of different concentrations of urea on the mRNA expression of selected genes in bovine endometrial cells with or without 100 ng/mL LPS for 24 h #.
| Gene | LPS | Urea (mmol/L) | COMB+ | |||
|---|---|---|---|---|---|---|
| 0 | 2.5 | 5.0 | 7.5 | |||
| - | 90 ± 34.8 | 90 ± 17.9 | 112 ± 47.8 | 86 ± 25.4 | 94 ± 15.2 | |
| + | 545 ± 97.3 | 816 ± 242 | 795 ± 263 | 697 ± 225 | 713 ± 101 ** | |
| - | 449 ± 110 | 547 ± 152 | 533 ± 210 | 517 ± 191 | 511 ± 76.7 | |
| + | 533 ± 171 | 532 ± 192 | 523 ± 179 | 652 ± 285 | 560 ± 95.7 | |
| - | 40,686 ± 7122 | 51,365 ± 6018 | 40,512 ± 8384 | 47,800 ± 11,001 | 45,091 ± 3920 | |
| + | 56,308 ± 12,006 | 41,976 ± 9441 | 40,360 ± 7702 | 46,944 ± 11,921 | 46,397 ± 4931 | |
| - | 1019 ± 471 | 1802 ± 283 | 2164 ± 923 | 2111 ± 337 | 1774 ± 278 | |
| + | 3386 ± 898 | 1613 ± 795 | 1295 ± 505 | 2098 ± 486 | 2099 ± 373 | |
| - | 334 ± 136 | 405 ± 142 | 289 ± 114 | 254 ± 119 | 320 ± 59.3 | |
| + | 340 ± 141 | 370 ± 148 | 381 ± 202 | 224 ± 52.9 | 329 ± 67.3 | |
| - | 3131 ± 1551 | 3403 ± 1470 | 3042 ± 1200 | 2418 ± 710 | 2998 ± 578 | |
| + | 3261 ± 1511 | 2687 ± 1071 | 3390 ± 1105 | 1666 ± 359 | 2751 ± 519 | |
# Values are calculated as mean relative expression (in arbitrary units) ± SEM with respect to the reference gene RN18S1 measured in the same samples. Results are combined from four experimental replicates/batches per treatment. There was no significant interaction (p > 0.05; ANOVA with randomised block design via a linear mixed-effects model) between the effect of urea and LPS treatment on the expression of any of the genes examined; + Shows the combined effect of LPS treatment across all the urea concentrations combined, n = 16. ** Significant difference (p < 0.001; t-test).